American International Group, Inc. Savara Inc Transaction History

American International Group, Inc.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$4.19 - $5.59 $1,604 - $2,140	-383 Reduced 0.85%	44,520 $221,000
Q4 2023 Feb 13, 2024	SELL	$3.18 - $4.9 $575 - $886	-181 Reduced 0.4%	44,903 $211,000
Q3 2023 Nov 13, 2023	BUY	$2.97 - $3.88 $24,909 - $32,541	8,387 Added 22.85%	45,084 $170,000
Q2 2023 Aug 04, 2023	BUY	$1.69 - $3.24 $62,017 - $118,898	36,697 New	36,697 $117,000
Q2 2021 Aug 13, 2021	SELL	$1.51 - $2.29 $42,376 - $64,266	-28,064 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$1.17 - $2.33 $87 - $174	75 Added 0.27%	28,064 $58,000
Q4 2020 Feb 12, 2021	SELL	$1.0 - $1.47 $803 - $1,180	-803 Reduced 2.79%	27,989 $32,000
Q3 2020 Nov 04, 2020	BUY	$1.09 - $2.21 $438 - $888	402 Added 1.42%	28,792 $31,000
Q2 2020 Aug 12, 2020	BUY	$1.8 - $3.05 $14,133 - $23,948	7,852 Added 38.23%	28,390 $71,000
Q1 2020 May 04, 2020	SELL	$1.91 - $4.08 $2,267 - $4,842	-1,187 Reduced 5.46%	20,538 $44,000
Q4 2019 Feb 05, 2020	SELL	$0.71 - $4.91 $129 - $893	-182 Reduced 0.83%	21,725 $97,000
Q3 2019 Nov 08, 2019	BUY	$2.16 - $3.2 $3,689 - $5,465	1,708 Added 8.46%	21,907 $58,000
Q2 2019 Aug 13, 2019	BUY	$2.37 - $11.7 $4,562 - $22,522	1,925 Added 10.53%	20,199 $48,000
Q1 2019 May 06, 2019	SELL	$6.71 - $8.6 $3,972 - $5,091	-592 Reduced 3.14%	18,274 $135,000
Q4 2018 Feb 13, 2019	SELL	$6.27 - $10.92 $909 - $1,583	-145 Reduced 0.76%	18,866 $143,000
Q3 2018 Nov 09, 2018	BUY	$10.49 - $12.87 $28,637 - $35,135	2,730 Added 16.77%	19,011 $212,000
Q2 2018 Aug 08, 2018	BUY	$8.55 - $13.76 $139,202 - $224,026	16,281 New	16,281 $184,000

129

158M

67.6K

29.4K

Ticker SVRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,043,000
Market Cap $377M
Description
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.